Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15169795 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophageal Neoplasms;   Stomach Neoplasms;   Neoplasm Metastasis
Intervention: Drug: capecitabine (Xeloda), oxaliplatin and bevacizumab (Avastin)
2 Completed A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: TS-1, oxaliplatin

Indicates status has not been verified in more than two years